Albert

Xiwan Jin Albert has extensive experience in equity investment and research, currently holding a position in equity investment at China Investment Corporation since March 2018. Prior to this role, Xiwan Jin worked in equity research focused on the healthcare sector at CCB International Holdings and 瑞信银行 from September 2016 to September 2016. Earlier career experience includes serving as R&D Group Lead at New Beta Innovation Canada Limited and as a Senior Research Assistant at HKUMed. Xiwan Jin holds a Master of Philosophy in Life Science and a Master of Science in Financial Analysis from The Hong Kong University of Science and Technology, alongside a Bachelor of Science in Biology, Bioengineering from the same institution. Additionally, Xiwan Jin studied at Utrecht University.